<DOC>
	<DOCNO>NCT00004129</DOCNO>
	<brief_summary>RATIONALE : Radioactive drug phosphorus 32 may able kill tumor cell . PURPOSE : This phase I trial study side effect best dose phosphorus 32 treat patient glioblastoma multiforme .</brief_summary>
	<brief_title>Phosphorus 32 Treating Patients With Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : - Determine dosimetry toxicity interstitial colloidal phosphorus P32 ( C P32 ) patient recurrent poor prognosis grade 4 astrocytoma . - Determine maximum tolerate dose C P32 administer directly tumor patient . - Determine maximum tolerate fractionate dose interstitial C P32 patient . - Determine therapeutic response rate acceptable single fractionate dos C P32 patient . OUTLINE : This dose-escalation study . Patients receive interstitial colloidal phosphorus P32 ( C P32 ) day 0 . Courses repeat every 4-6 week absence disease progression unacceptable toxicity . Cohorts 3 patient receive escalate dos C P32 maximum tolerate dose ( MTD ) determine . The MTD define dose 2 3 patient experience dose-limiting toxicity . Patients follow 1 , 2 , 4 , 6 , 9 , 15 , 24 week . PROJECTED ACCRUAL : A minimum 12 patient accrue study .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven grade 4 astrocytoma ( glioblastoma ) Failed external beam radiotherapy and/or surgery OR Poor prognosis disease No clinical evidence metastatic disease within CNS primary tumor site Stereotactic biopsy gross total excision residual tumor Lesion 3 5 cm size No spinal cord tumor ( ) PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm3 Neutrophil count least 1,900/mm3 Platelet count least 100,000/mm3 Hemoglobin least 9 g/dL ( transfusion allow ) Hepatic : Not specify Renal : Creatinine great 1.5 mg/dL BUN le 25 mg/dL Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>